METHOD FOR PREDICTING THE CLINICAL RESPONSE OF ONCOLYTIC PARVOVIRUS H1 (H-1PV) TREATMENT IN A PATIENT SUSPECTED OF SUFFERING FROM CANCER BY MEASURING THE EXPRESSION LEVELS OF LAMININS AND/OR GALECTINS AS BIOMARKERS IN A PATIENT'S SAMPLE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20210340630A1
SERIAL NO

17307236

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention concerns the use of laminins and/or galectins as biomarker(s) for predicting the outcome of the treatment with oncolytic parvovirus H1 (H-1 PV) in a cancer patient.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DEUTSCHES KREBS FORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTSNot Provided

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
FERREIRA, Tiago Heidelberg, DE 1 0
GREWENIG, Annabel Heidelberg, DE 1 0
KULKARNI, Amit Heidelberg, DE 85 1530
MARCHINI, Antonio Luxembourg, LU 15 9
MARTTILA, Tiina Karlsruhe, DE 3 0
ROMMELAERE, Jean Heidelberg, DE 48 78

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation